http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747063-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a9057130bebc2a1a84245318386110d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
filingDate 1992-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd75868f9c1dd58cbc6b908e57f2b5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9bdf72320a95f6b07d1020cc59069c
publicationDate 1998-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5747063-A
titleOfInvention Therapeutic elements for the oral administration of medication to animals and process for making same
abstract The therapeutic elements for oral administration of medication to animals comprise an active principle contained in a craved for envelope. The envelope (1) comprises, in admixture, one or more craved for materials and one or more substances agglomerating the craved for materials, the envelope possessing a high mechanical and thermal resistance, and being previously formed into a hollow shape appropriate for consumption by the animal, and defining an internal volume, such internal volume being filled by a craved for binder (3) and comprising the active principle (2), the binder closely conforming the internal shape of the envelope (1) in order to provide a continuity between the envelope (1) and the active principle (2).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016073410-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6866862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006218848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7052712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7067142-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012032182-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11654107-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9216213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6716448-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524067-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012145577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006121095-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11524068-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003138472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004180078-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003097992-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003099688-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004234570-A1
priorityDate 1989-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4666717-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240826-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3607295-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8912393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3829564-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129049279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19917616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11535
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397173

Total number of triples: 48.